In this presentation Dr. John Daly, Chief Medical Officer (CMO) for COLA,focuses on the use of the laboratory analysis of BNP and N-Terminal Pro-BNP in the work-up of cardiac failure and its distinction from respiratory related dyspnea.  The differences between these two hormones are examined, and while both are excellent markers, it is important to understand wherein the analyses and metabolism differ.  Finally, there is discussion of use and utility of serial measurements of these hormones in patients with known heart failure and in patient populations with stable angina and acute coronary syndrome.

Click the image below to view this informative video that runs around 6 minutes.

John Daly, MD

Prior to his role as Chief Medical Officer at COLA, Dr. John Daly was the Director of Clinical Laboratories for the Duke University Health System from 2005-2009. A longtime resident of Durham, NC, Dr. Daly was quite active in the local medical community, joining the staffs of three area hospitals and serving as a member of various hospital committees. He earned his M. D. at Cornell University Medical College, and performed his internship and residency in pathology at Duke University Medical Center. He also is a veteran of the U. S. Navy.

About The Author

Prior to his role as Chief Medical Officer at COLA, Dr. John Daly was the Director of Clinical Laboratories for the Duke University Health System from 2005-2009. A longtime resident of Durham, NC, Dr. Daly was quite active in the local medical community, joining the staffs of three area hospitals and serving as a member of various hospital committees. He earned his M. D. at Cornell University Medical College, and performed his internship and residency in pathology at Duke University Medical Center. He also is a veteran of the U. S. Navy.

Related Posts

Send this to a friend